throbber
Paul Anthony Dalby, FRSC, AMIChemE
`Dept. Biochemical Engineering, University College London, Gower Street, London WC1E 6BT
`
`EDUCATION AND CAREER
`• 2016 - present Deputy Head, Department of Biochemical Engineering (Research), UCL.
`• 2016 - present Co-Director of EPSRC Future Targeted Healthcare Manufacturing Hub, UCL.
`• 2013 - present Professor at University College London, Dept. Biochemical Engineering
`Director of EPSRC Centre for Doctoral Training in Innovative Manufacturing, UCL.
`• 2012 - 2022
`Co-Director of EPSRC Centre for Innovative Manufacturing, UCL.
`• 2011 - 2016
`Reader at University College London, Dept. Biochemical Engineering
`• 2009 - 2013
`Senior Lecturer at University College London, Dept. Biochemical Engineering
`• 2007 - 2009
`Lecturer at University College London, Dept. Biochemical Engineering
`• 2000 - 2007
`Postdoctoral fellowship at University of Pennsylvania, School of Medicine
`• 1998 - 2000
`Protein design and evolution with Prof. W. F. DeGrado (member of the National Academy)
`Projects: Development of novel binding proteins
`In vitro evolution of new catalytic function
`Collaboration with Ronald H. Hoess (Dupont)
`Carried out phage display, protein engineering, purification, formulation and
`characterisation by CD, fluorescence, enzymology, computer modeling and bioinformatics
`Ph.D. Cambridge University, MRC Centre for Protein Engineering
`Protein folding and engineering with Prof. Sir A. R. Fersht, FRS
`Projects: Folding pathway of Barnase
`My work involved molecular biology, PCR, mutagenesis, expression and purification,
`organic synthesis, circular-dichroism, fluorescence and UV-Visible spectroscopy,
`calorimetry, stopped-flow kinetics, temperature-jump, pulsed quench-flow and NMR.
`
`B.A. (Hons)/ M.A. Natural Sciences (First class)
`Gonville & Caius College, Cambridge University
`Studied Chemistry, Biochemistry, Physics, and Mathematics
`Project: Synthesis of short antimicrobial peptides (organic chemistry)
`
`• 1994 - 1998
`
`• 1991 - 1994
`
`AWARDS
`• 2010
`• 2010
`• 2008-2010
`• 2001
`• 1994-1997
`• 1993-1994
`• 1993
`
`IChemE Innovation and Excellence Award in Bioprocessing (for the BiCE team)
`Royal Society of Chemistry Rita and John Cornforth Award (for the BiCE team)
`Evonik European Science-to-Business Award for Industrial Biotechnology
`Second prize for young researcher at SCI: London's Chemistry meeting
`Gonville & Caius College Dunlop Scholarship
`Gonville & Caius College Senior Scholarship
`James Arthur Ramsay Prize in Chemistry & Biology
`
`PROFESSIONAL AFFILIATIONS
`Scientific Advisory Board for UMabs, USA/China.
`• 2022-
`EPSRC Strategic Advisory Team for Manufacturing the Future.
`• 2020-
`EPSRC Healthcare Council-SAN-SAT Working Group.
`• 2020-
`Scientific Advisory Board for Leukocare, Germany.
`• 2020-
`Co-Founder of Roxijen Ltd.
`• 2020-
`UKRI FLF Peer Review College Member
`• 2018
`External examiner MSc Biological Engineering, University of Sheffield
`• 2017- 2020
`EPSRC College member
`• 2016-
`Elected Management Board Member of BBSRC BioProNet
`• 2015-
`Editorial Board Member of Scientific Reports (a Nature Journal)
`• 2015-
`Committee Member of the RSC Chemistry Biology Interface Division
`• 2014-2016
`
`MPI EXHIBIT 1008 PAGE 1
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 1 of 22
`
`

`

`Panel Member of the Innovate UK IB Catalyst.
`Fellow of the Royal Society of Chemistry (Member since 2005)
`Steering Group Member of the BBSRC Bioprocess Research Industry Club (BRIC)
`Editor-in-Chief of 'Current Biotechnology', since its launch (issue 1: Feb 2012)
`Editor-in-Chief of the 'Open Biotechnology Journal' (Editorial board member since 2007)
`BBSRC Research Grant Panel Committee D as core member
`BBSRC Research Grant Panel Committee C as pool member
`Chair Royal Society of Chemistry - Biotechnology Group (Member since 2003)
`Editorial Board Member of ‘Enzyme Engineering'
`Editorial Advisory Board for 'Recent Patents in Biotechnology'
`Member of the Protein Society
`Associate Member of the Institute of Chemical Engineers
`Member of the American Chemical Society
`
`• 2014-2016
`• 2013-
`• 2013- 2016
`• 2011- 2014
`• 2010- 2014
`• 2011- 2014
`• 2010- 2011
`• 2008-
`• 2011- 2013
`• 2006- 2008
`• 2006- 2013
`• 2003-
`• 2001- 2005
`
`FACULTY, UCL, MULTI-INSTITUTIONAL ROLES
`• 2017 - 2021
`Faculty REF Impact lead
`• 2017 - 2021
`Dept Biochemical Engineering REF lead
`• 2016 -
`Chair of the UCL SLMS Technology Innovation Network for Biologics
`• 2016 -
`Member of Faculty of Engineering Sciences Research Directors Committee
`• 2015 - 2022
`Member of UCL CDT Directors Committee
`• 2012 - 2022
`Director of EPSRC Multi-Institutional Centre for Doctoral Training
`• 2008 -
`Genetic Modification Safety Committee
`• 2016 - 2017
`Member of Faculty of Engineering Sciences Research Degrees Committee
`• 2012 - 2014
`Chair of BBSRC Multi-Institutional Doctoral Training Programme Recruitment Panel
`• 2012 - 2014
`BBSRC Multi-Institutional Doctoral Training Programme Management Board
`• 2005 - 2008
`Engineering Faculty Undergraduate Degree Committee
`
`TEACHING ROLES
`Course coordinator MBI® in Antibody Targeted Therapy
`• 2017 -
`Course coordinator (Yr3), BENG0031. Chemistry for Biochemical Engineers
`• 2016 -
`• 2014 -
`BENG101P. Lectures (formulation, vaccines) Introduction to Biochemical Engineering
`Course coordinator (Yr2), BENG0013. Biochemistry for Biochemical Engineers
`• 2013 -
`• 2007 -
`MBI® in Design of Experiments for Bioprocess Optimisation. Case study lecture.
`• 2000 -
`G004/M002 Advanced Bioreactor Engineering - Lectures (MSc & Yr4)
`• 2000 -
`Research project supervision (Yr4, MSc, MRes & Biotechnology BSc)
`• 2012 - 2018
`BBSRC LIDO Doctoral Training Programme. Lecture- Biological design and engineering.
`Course coordinator (Yr 4), BENGM005/6, 3010 Undergraduate research projects
`• 2003 - 2017
`Course coordinator and lecturer, MBI® in biocatalysis
`• 2005 - 2017
`• 2001 - 2014
`BENG2006 Biocatalyst design lectures (Yr3 Biotechnology)
`Course coordinator (Yr1), BENG1001 Introduction to Biochemical Engineering
`• 2005 - 2014
`• 2000 - 2013
`G17 & BIOC2007 Biochemistry for Biochemical Engineers - Workshops (MSc & Yr2)
`• 2006 - 2009
`BIOC2008 Biochemistry for Biochemical Engineers - Workshops (Yr3)
`• 2003 - 2008
`BIOC1001 Biochemistry for Engineers - Industrial biocatalysis lectures (Yr1)
`• 2000 - 2008
`PhD/EngD training day coordinator
`• 2002 - 2004
`E129/E105/G23 - Affinity Chromatography for undergraduate and MSc
`Biochemical Engineering in the 21st Century - Coordinator (Yr1)
`• 2001 - 2005
`• 2000 - 2005
`MBI® in biocatalysis - Enzyme design lecture
`
`TUTORING ROLES AT DEPT BIOCHEMICAL ENGINEERING, UCL
`Chair of Departmental Research Committee
`• 2016 -
`Member of Departmental Finance Committee
`• 2016 -
`Departmental Tutor for Admissions to Doctoral Research
`• 2008 - 2016
`
`MPI EXHIBIT 1008 PAGE 2
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 2 of 22
`
`

`

`Mentor to Darren Nesbeth, a new probationary lecturer in the Department
`Mentor to Martina Micheletti, a new probationary lecturer in the Department
`Chair of undergraduate departmental staff student consultative committee
`Crook (UG) and Beaker (PG) Society Liaison
`Departmental Tutor to Undergraduates
`Tutor to 1st year undergraduates
` Organised BE in 21st century seminars to help students see broader picture.
`Incorporated BE in 21st century seminars into E100 course to make examinable.
`
`Undergraduate Admissions tutor
` Developed recruiting strategies, including Video/CD, mailshot via UCAS
`
`Increased total number of applications from 80 to 160 per year
`Convenor of undergraduate departmental staff student consultative committee
`Undergraduate recruitment coordinator
`
`• 2010 - 2012
`• 2007 - 2009
`• 2005 - 2014
`• 2005 - 2008
`• 2005 - 2008
`• 2000 - 2007
`
`
`• 2000 - 2005
`
`
`• 2003 - 2005
`• 2002 - 2005
`
`PUBLICATIONS: H-index 30 (WoK), 35 (Google Scholar)
`
`Published (114) including 4 book chapters, and one book
`
`1. Zhang C, Berg A, Joe CCD, Dalby PA, Douglas AD (2023) Lyophilization to enable distribution of simian
`adenovirus-vectored vaccines without refrigeration. Nature Vaccines. in press.
`
`
`2. Zhang, H., Dalby, P.A. (2022) Stability convergence in antibody coformulations. Molecular Pharmaceutics
`19 (11) 4098-4110.
`
`
`3. Lee, W., Pradhan, S., Zhang, C., Venanzi, N., Li, W., Goldrick, S., Dalby, P.A. (2022) Directed evolution
`for soluble and active periplasmic expression of bovine enterokinase in Escherichia coli. Scientific Reports
`
`
`4. Lee, W., Pradhan, S., Zhang, C., Venanzi, N., Li, W., Goldrick, S., Dalby, P.A. (2022) Directed evolution
`for soluble and active periplasmic expression of bovine enterokinase in Escherichia coli. Research Square
`(pre-print): doi.org/10.21203/rs.3.rs-1522473/v1
`
`
`5. Xiaochen Lyu, Qichao Zhao, Julia Hui, Tiffany Wang, Mengyi Lin, Keying Wang, Jialing Zhang,
`Jiaqian Shentu, Paul A Dalby, Hongyu Zhang, Bo Liu (2022). The Global Landscape of Approved
`Antibody Therapies. Antibody Therapeutics 5(4) 233-257.
`
`
`6. Li Y, Dalby PA (2022) Engineering of enzymes using non-natural amino acids. Bioscience Reports 42(8)
`BSR20220168.
`
`
`7. Kellerman MAW, Almeida T, Rudd TR, Matejtschuk P, Dalby PA (2022) NMR Reveals Functionally
`Relevant Thermally-induced Structural Changes within the Native Ensemble of G-CSF. Molecular
`Pharmaceutics 19(9) 3242-3255.
`
`
`8. Lalaurie CJ, Splevins A, Barata TS, Bunting KA, Higazi DR, Zloh M, Spiteri VA, Perkins SJ, Dalby PA
`(2022) Elucidation of critical pH-dependent structural changes in Botulinum Neurotoxin E. Journal of
`Structural Biology 214(3) 107876.
`
`
`9. Yu HR, Ma S, Li YW, Dalby PA (2022) Hotspots making directed evolution easier. Biotechnol. Adv. 56,
`107926.
`
`
`10. Wood VE, Groves K, Wong LM, Kong L, Bird C, Wadhwa M, Quaglia M, Matejtschuk P, Dalby PA
`(2022) Protein engineering and HDX identifies structural regions of G-CSF critical to its stability and
`aggregation. Molecular Pharmaceutics 19(2), 616-629.
`
`MPI EXHIBIT 1008 PAGE 3
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 3 of 22
`
`

`

`
`11. Phattaraporn Morris, Ribia García-Arrazola, Leonardo Rios-Solis, Paul A. Dalby. (2021) Biophysical
`characterization of the inactivation of E. coli transketolase by aqueous co-solvents. Scientific Reports.
`11(1), 23584.
`
`
`12. Vaud, S, Pearcy, N, Hanzevacki, M, Van Hagen, AMW, Abdelrazig, S, Safo, L, Ehsaan, M, Jonczyk, M,
`Millat, T, Craig, S, Spence, E, Fothergill, J, Bommareddy, RR, Colin, PY, Twycross, J, Dalby, PA,
`Minton, NP, Jager, CM, Kim, DH, Yu, JP, Maness, PC, Lynch, S, Eckert, CA, Conradie, A (Conradie,
`Alex) 2 Bryan, SJ (Bryan, Samantha J (2021) Engineering improved ethylene production: Leveraging
`systems biology and adaptive laboratory evolution. Metabolic Engineering. 67, 308-320.
`
`
`13. Groves, Kate; Ashcroft, Alison; Cryar, Adam; Sula, Altin; Wallace, Bonnie Ann; Stocks, Bradley; Burns,
`Christopher; Cooper-Shepherd, Dale; De Lorenzi, Ersilia; Rodriguez, Elizabeth ; Zhang, Hongyu; Ault,
`James; Ferguson, Jackie; Phillips, Jonathan; Pacholarz, Kamila; Thalassinos, Konstantinos; Luckau, Luise;
`Ashton, Lorna; Durrant, Oliver; Barran, Perdita; Dalby, Paul; Vicedo, Pau; Colombo, Raffaella; Davis,
`Rachel; Parakra, Rinky; Upton, Rosie; Hill, Sarah; Wood, Victoria; Soloviev, Zoja; Quaglia, Milena (2021)
`A reference protocol to assess analytical performance of higher order structural analysis measurements:
`results from an inter-laboratory comparison. Analytical Chem. 93 (26), 9041-9048.
`doi.org/10.1021/acs.analchem.0c04625
`
`
`14. Zhang H, Yang Y, Zhang C, Farid SS, Dalby PA (2021) Machine learning reveals hidden stability code in
`protein native fluorescence. Computational and Structural Biotechnology Journal. 19, 2750-2760.
`
`15. Cheng Zhang, Nuria Codina, Jiazhi Tang, Haoran Yu, Nesrine Chakroun, Frank Kozielski, Paul A. Dalby.
`(2021) Comparison of the pH- and thermally-induced fluctuations of a therapeutic antibody Fab fragment
`by molecular dynamics simulation. Computational and Structural Biotechnology Journal. 19, 2726-2741.
`
`16. Spiteri V, Doutch J, Rambo RP, Gor J, Dalby PA, Perkins SJ (2021) Solution structure of deglycosylated
`human IgG1 shows the role of CH2 glycans in its conformation. Biophysical Journal 200, 1814-1834.
`doi.org/10.1016/j.bpj.2021.02.038
`
`17. Hales JE, Aoudjane S, Aeppli G, Dalby PA (2021). Proof-of-concept analytical instrument for label-free
`optical deconvolution of protein species in a mixture. Journal of Chromatography A 1641, 461968.
`
`18. Colin PY, Dalby PA (2020) Functional and computational identification of a rescue mutation near the
`active site of an mRNA methyltransferase. Scientific Reports 10, (1) 21841
`
`19. Zhang H, Dalby PA (2020) Stability enhancement in a mAB:Fab protein coformulation. Scientific Reports
`10, 1-11. Doi.org/10.1038/s41598-020-77989-w
`
`20. Wood VE, Groves K, Cryar A, Quaglia M, Matejtschuk P, Dalby PA (2020) HDX and in-silico docking
`reveal that excipients stabilise G-CSF via a combination of preferential exclusion and specific hotspot
`interactions. Molecular Pharmaceutics 17 (12) 4637-4651. doi.org/10.1021/acs.molpharmaceut.0c00877
`
`21. Chauhan VM, Zhang H, Dalby PA, Aylott JW (2020) Advancements in the co-formulation of biologic
`therapeutics. J Controlled Release 327, 397-405.
`
`22. Wilkinson HC, Dalby PA (2020) Fine-tuning the activity and stability of an evolved enzyme active-site
`through non-canonical amino-acids. FEBS J 288, 1935-1955. DOI: 10.1111/febs.15560
`
`
`MPI EXHIBIT 1008 PAGE 4
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 4 of 22
`
`

`

`23. Yu H, Dalby PA (2020) A beginner’s guide to molecular dynamics simulations and the identification of
`cross-correlation networks for enzyme engineering. Methods Enzymology. 643, 15-49.
`
`24. Wilkinson HC, Dalby PA (2020) The Two-Species Model of transketolase explains donor substrate-
`binding, inhibition and heat-activation. Scientific Reports 10, 4148.
`
`25. Yu H, Hernandez-Lopez RI, Steadman D, Mendez-Sanchez D, Higson S, Cazares-Korner A, Sheppard TD,
`Ward JM, Hailes HC, Dalby PA (2020) Engineering transketolase to accept both unnatural donor and
`acceptor substrates and produce α-hydroxyketones. Febs J. 287, 1758-1776. DOI: 10.1111/febs.15108
`
`26. Wilkinson HC, Dalby PA (2019) Novel insights into transketolase activation by cofactor binding identifies
`two native species subpopulations. Scientific Reports 9, 16116.
`
`27. Hales JE, Matmon G, Dalby PA, Ward JM, Aeppli G. (2019) Virus lasers for biological detection. Nature
`Communications 10:3594. DOI: 10.1038/s41467-019-11604-z
`
`28. Nuria Codina, Cheng Zhang, Nesrine Chakroun, and Paul A. Dalby. (2019) Insights into the stability of a
`therapeutic antibody Fab fragment by molecular dynamics and its stabilization by computational design.
`BioArXiv.
`
`29. Nuria Codina, David Hilton, Cheng Zhang, Nesrine Chakroun, Shahina S Ahmad, Stephen J Perkins, Paul
`A Dalby. (2019) An expanded conformation of an antibody Fab region by X-ray scattering, molecular
`dynamics and smFRET identifies an aggregation mechanism. Journal of Molecular Biology 431(7):1409-
`1425. doi: 10.1016/j.jmb.2019.02.009
`
`30. Mathew J. Robinson, Paul Matejtschuk, Colin Longstaff, Paul A. Dalby. (2019) Selective stabilisation and
`destabilisation of protein domains in tissue-type plasminogen activator using formulation excipients.
`Molecular Pharmaceutics. 16(2): 744-755. DOI: 10.1021/acs.molpharmaceut.8b01024
`
`31. Yu, H, Dalby, PA. (2018) Exploiting correlated molecular-dynamics networks to counteract enzyme
`activity-stability trade-off. Proc. Natl. Acad. Sci. USA 115 (52) E12192-E12200.
`
`32. Yu, H, Dalby, PA. (2018) Coupled molecular dynamics mediate long and short-range epistasis between
`mutations that affect stability and aggregation kinetics. Proc. Natl. Acad. Sci. USA 115 (47) E11043-
`E11052.
`
`33. Pandya A, Howard MJ, Zloh M, Dalby PA. (2018) An evaluation of the potential of NMR spectroscopy
`and computational modelling methods to inform biopharmaceutical formulations. Pharmaceutics 10 (4),
`165. DOI: 10.3390/pharmaceutics10040165
`
`34. Zhang C, Samad M, Yu H, Chakroun N, Hilton D, Dalby PA. (2018) Computational-design to reduce
`conformational flexibility and aggregation rates of an antibody Fab fragment. Molecular Pharmaceutics.
`15 (8), 3079-3092. DOI: 10.1021/acs.molpharmaceut.8b00186
`
`35. Robinson MJ, Matejtschuk P, Bristow AF, Dalby PA. (2018) Tm-values and unfolded fraction can predict
`aggregation rates for GCSF variant formulations, but not under predominantly native conditions. Molecular
`Pharmaceutics. 15 (1), 256-267. DOI: 10.1021/acs.molpharmaceut.7b00876
`
`36. Cardenas-Fernandez M, Bawn M, Hamley-Bennett C, Bharat PKV, Subrizi F, Suhaili N, Ward D, Bourdin
`S, Dalby PA, Hailes HC, Hewitson P, Ignatova S, Kontoravdi C, Leak D, Shah N, Sheppard TD, Ward JM,
`
`MPI EXHIBIT 1008 PAGE 5
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 5 of 22
`
`

`

`Lye GJ. (2017) An integrated biorefinery concept for conversion of sugar beet pulp into value-added
`chemicals and pharmaceutical intermediates. Faraday Discussions, 202, 415-431.
`
`37. Haoran Yu, Yihan Yan, Cheng Zhang, Paul A. Dalby (2017) Two strategies to engineer flexible loops for
`improved enzyme thermostability. Scientific Reports, 7, 41212.
`
`
`38. Affaticati PE, Dai SB, Payongsri D, Hailes HC, Tittmann K, Dalby PA. (2016) Structural analysis of an
`evolved transketolase reveals divergent binding modes. Scientific Reports, 6, 35716
`
`39. Barata T.S., Zhang C., Dalby P.A., Brocchini S., Zloh M. (2016) Int J. Mol. Sci. 17(6):853. Identification
`of Protein–Excipient Interaction Hotspots Using Computational Approaches. doi:10.3390/ijms17060853
`
`40. P. Morris, L. Rios-Solis, R. García-Arrazola, G. J. Lye, P. A. Dalby. (2016) Enzyme and Microbial
`Technology 89:85-91. Impact of cofactor-binding loop mutations on thermotolerance and activity of E. coli
`transketolase. doi:10.1016/j.enzmictec.2016.04.003
`
`41. F. Subrizi, M. Cardenas-Fernandez, G. J. Lye, J. M. Ward, P. A. Dalby, T. D. Sheppard, H. C. Hailes
`(2016) Green Chemistry. 18:3158-3165. Transketolase catalysed upgrading of L-arabinose: the one-step
`stereoselective synthesis of L-gluco-heptulose. DOI: 10.1039/C5GC02660A
`
`42. Chakroun N, Hilton D, Ahmad S, Platt G, Dalby PA. (2016) Molecular Pharmaceutics. 13(2):307-319.
`Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment. DOI:
`10.1021/acs.molpharmaceut.5b00387
`
`43. Dawid Deszcz, Pierre Affaticati, Nadine Ladkau, Alex Gegel, John M. Ward, Helen C. Hailes, Paul A.
`Dalby. (2015) FEBS J. 13:2512-2526. Single active-site mutants are sufficient to enhance serine:pyruvate
`α-transaminase activity in an ω-transaminase. DOI: 10.1111/febs.13293
`
`
`44. Payongsri P, Steadman D, Hailes HC, Dalby PA. (2015) Enzyme Microb Technol 71:45-52. Second
`generation engineering of transketolase for polar aromatic aldehyde substrates.
`10.1016/j.enzmictec.2015.01.008
`
`
`45. Lucy E. Rayner, Gar Kay Hui, Jayesh Gor, Richard K. Heenan, Paul A. Dalby, Stephen J. Perkins (2015) J
`Biol Chem 290: 8420-8438. The solution structures of two human IgG1 antibodies show conformational
`stability and accommodate their C1q and FCγR ligands.
`
`
`46. Rios-Solis L, Morris P, Grant C, Odeleye A, Hailes HC, Ward JM, Dalby PA, Baganz F, Lye GJ (2015)
`Chem Eng Sci 122:360-372. Modelling and optimisation of the one-pot, multi-enzymatic synthesis of chiral
`amino-alcohols based on microscale kinetic parameter determination
`
`
`47. Du CJ, Rios-Solis L, Ward JM, Dalby PA, Lye GJ (2014) Biocatalysis and Biotransformation 32, 302-313.
`Evaluation of CV2025 w-transaminase for the bioconversion of lignin breakdown products into value-
`added chemicals: synthesis of vanillylamine from vanillin
`
`
`48. Chris Grant, Dawid Deszcz, Yu-Chia Wei, Rubéns Julio Martínez-Torres, Phattaraporn Morris, Thomas
`Folliard, Rakesh Sreenivasan, John Ward, Paul Dalby, John M. Woodley & Frank Baganz (2014) Scientific
`Reports 4, 5844. Identification and use of an alkane transporter plug-in for applications in biocatalysis and
`whole-cell biosensing of alkanes. Doi:10.1038/srep05844
`
`
`49. Lucy E. Rayner, Gar Kay Hui, Jayesh Gor, Richard K. Heenan, Paul A. Dalby and Stephen J. Perkins
`(2014) Journal of Biological Chemistry. 289(30):20740-20756. The Fab Conformations in the Solution
`
`MPI EXHIBIT 1008 PAGE 6
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 6 of 22
`
`

`

`Structure of Human IgG4 restricts Access to its Fc Region: Implications for Functional Activity. doi:
`10.1074/jbc.M114.572404
`
`
`50. Dalby PA (2014). The role of directed protein evolution in synthetic biology. In Synthetic Biology, Volume
`1. pp 79-105. RSC Books. 10.1039/9781849737845-00079
`
`
`51. Sagar, D.M., Aoudjane, S., Gaudet, M., Aeppli, G., Dalby, P.A. (2013) Scientific Reports 3:2130. Optically
`Induced Thermal Gradients for Protein Characterization in Nanolitre-scale Samples In Microfluidic
`Devices. DOI:10.1038/srep02130
`
`
`52. Lucy E. Rayner, Nilufar Kadkhodayi-Kholghi, Jayesh Gor, Paul A. Dalby, Stephen J. Perkins, (2013) J.
`Mol. Biol. 425:506-523. The solution structure of rabbit IgG accounts for its interactions with the Fc
`receptor and complement C1q and its conformational stability.
`
`
`53. Polykarpou, E.M., Dalby, P.A., Papageorgiou, L.G. (2012) Biochemical Engineering Journal 67:186-193.
`Novel efficient optimisation systems for purification process synthesis.
`
`
`54. Polykarpou, E.M., Dalby, P.A., Papageorgiou, L.G. (2012) Chemical Engineering Research and Design.
`90(9):1262-1270. An MILP formulation for the synthesis of protein purification processes.
`DOI: 10.1016/j.cherd.2011.11.021.
`
`
`55. Grant, Y., Dalby, P.A., Matejtschuk, P. (2012) American Pharmaceutical Review. 15(2):75-80. Use of
`design of experiment and micro-scale down strategies in formulation and cycle development for
`lyophilization.
`
`
`56. Panwajee Payongsri, David Steadman, John Strafford, Andrew MacMurray, Helen C. Hailes, Paul A.
`Dalby (2012) Org. Biomol. Chem. 10(45):9021-9029. Rational substrate and enzyme engineering of
`transketolase for aromatics. DOI: 10.1039/c2ob25751c.
`
`
`57. Ordidge G.C., Mannall, G., Liddell, J., Dalby, P.A., Micheletti, M. (2012) Biotechnology Progress
`28(2):435-444. A generic hierarchical screening method for the analysis of microscale refolds using an
`automated robotic platform. DOI: 10.1002/btpr.1502
`
`
`58. Robert Patterson, Jessica Nerren, Michael Kogut, Pinar Court, Bernardo Villarreal-Ramos, Hans-Martin
`Seyfert, Paul A. Dalby, Dirk Werling (2012) Developmental & Comparative Immunology 37(1):107-114.
`Yeast-surface expressed BVDV E2 protein induces a Th1/Th2 response in naïve T cells.
`DOI: 10.1016/j.dci.2011.10.009
`
`
`59. Grant, Y., Matejtschuk, P., Bird, C., Wadhwa, M., Dalby, P.A. (2012) Biotechnol. Letts. 34(4):641-648.
`Rapid identification and optimisation of freeze drying formulation using microscale and design of
`experiment approaches: A case study using granulocyte colony stimulating factor (G-CSF). DOI:
`10.1007/s10529-011-0822-2
`
`
`60. John Strafford, Panwajee Payongsri, Edward G. Hibbert, Phattaraporn Morris, Sukhjeet S. Batth, David
`Steadman, Mark E. B. Smith, John Ward, Helen C. Hailes, Paul A. Dalby (2012) J. Biotechnol. 157(1):
`237-245. Directed evolution to re-adapt a co-evolved network within an enzyme.
`DOI: 10.1016/j.jbiotec.2011.11.017
`
`
`61. Polykarpou, E.M., Dalby, P.A., Papageorgiou, L.G. (2012) Biotechnology Progress. 27(6): 1653-1660.
`Optimal synthesis of chromatographic trains for downstream protein processing. DOI: 10.1002/btpr.670
`
`
`
`MPI EXHIBIT 1008 PAGE 7
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 7 of 22
`
`

`

`62. Dalby PA, Ward JM, and Hailes HC (2011). C-C Bond Formation Using TDP Dependent Enzymes. In
`Comprehensive Chirality, Ed, Hisashi Yamamoto and Erick Carreira. Elsevier, Oxford, UK.
`
`
`63. L. Rios-Solis, M. Halim, A. Cázares, P. Morris, J. M. Ward, H.C. Hailes, P.A. Dalby, F. Baganz, G. J. Lye
`(2011) Biocatalysis and Biotransformation.29(5):192-203. A toolbox approach for the rapid evaluation of
`multi-step enzymatic syntheses comprising a “mix and match” E. coli expression system with microscale
`experimentation. DOI: 10.3109/10242422.2011.609589
`
`
`64. Parker, B.M., Taylor, I., Woodley, J.M., Ward, J.M., Dalby, P.A. (2011) J. Biotechnol. 155(4):396-405.
`Directed evolution of a thermostable L-aminoacylase biocatalyst. DOI:10.1016/j.jbiotec.2011.07.029
`
`
`65. Jahromi, R.R.F., Morris, P., Martinez-Torres, R.J., Dalby, P.A. (2011) J. Biotechnol.155(2):209-216.
`Structural stability of E. coli transketolase to temperature and pH denaturation. DOI
`10.1016/j.jbiotec.2011.06.023
`
`
`66. Dalby, P. and DeGrado B. (2011) Current Opinion in Structural Biology 21:450-451. Engineering and
`Design. DOI: 10.1016/j.sbi.2011.06.003
`
`
`67. Dalby, P.A. (2011) Current Opinion in Structural Biology 21:473-480. Strategy and success for the
`directed evolution of enzymes. DOI 10.1016/j.sbi.2011.05.003
`
`
`68. Lye, G.J., Dalby, P.A., Baganz, F., Ward, J.M and Hailes, H.C. (2011). Biocatalysis is the future… the
`future is now! The Chemical Engineer, issue 839 (May), 36-38.
`
`
`69. Mahendrarajah, K., Dalby, P.A., Wilkinson, B. Jackson, S.E. & Main, E.R.G. (2011) Anal Biochem
`411:155-157. A high throughput fluorescence chemical denaturation assay as a general screen for protein-
`ligand binding. DOI 10.1016/j.ab.2010.12.001
`
`
`70. Ahmad, S.S., Dalby, P.A. (2011) Biotechnol. Bioeng. 108(2):322-332. Thermodynamic parameters for salt-
`induced reversible protein precipitation from automated microscale experiments. (DOI: 10.1002/bit.22957)
`
`
`71. Hailes, H.C, Dalby, P.A., Lye, G. J., Baganz, F., Micheletti, M., Szita, N., Ward, J.M. (2010) Current
`Organic Chemistry. 14(17):1883-1893. α,α'-Dihydroxy Ketones and 2-Amino-1,3-diols: Synthetic and
`Process Strategies using Biocatalysts.
`
`
`72. James L. Galman, David Steadman, Sarah Bacon, Phattaraporn Morris, Lydia G. Crago, Mark E.B. Smith,
`John Ward, Paul A. Dalby and Helen C. Hailes (2010) ChemComm 46(40):7608-7610. α,α’-
`Dihydroxyketone formation using aromatic and heteroaromatic aldehydes with evolved transketolase
`enzymes.
`
`
`73. Abe, Y., Gor, J., Bracewell, D.G., Perkins, S.J., Dalby, P.A. (2010) Biochem. J. 432(1):101-111. Masking
`of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody
`function and therapy. (DOI: 10.1042/BJ20100641)
`
`
`74. Gaudet, M., Remtulla, N., Jackson, S.E., Main, E.R.G., Bracewell, D.G., Aeppli, G., Dalby, P.A. (2010)
`Protein Science. 19, 1544-1554. Protein denaturation and protein:drug interactions from intrinsic protein
`fluorescence measurements at the nanolitre scale. (DOI: 10.1002/pro.433)
`
`
`75. Cázares, A., Galman, J.L., Crago, L.G., Smith, M.E.B., Strafford, J., Ríos-Solís, L., Lye, G.J., Dalby, P.A.,
`Hailes, H.C. (2010) Organic & Biomolecular Chemistry. 8(6), 1301-1309. Non-alpha-hydroxylated
`aldehydes with evolved transketolase enzymes DOI: 10.1039/b924144b Cover of issue 8(6) 2010, March
`21.
`
`MPI EXHIBIT 1008 PAGE 8
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 8 of 22
`
`

`

`
`76. Smith, M.E.B., Chen, B.H., Hibbert, E.G., Kaulmann, U., Smithies, K., Galman, J.L., Baganz, F., Dalby,
`P.A., Hailes, H.C., Lye, G.J., Ward, J.M., Woodley, J.M., Micheletti, M. (2010) Org. Proc. Res. Dev.
`14(1), 99-107. A Multi-Disciplinary Approach Toward the Rapid and Preparative Scale Biocatalytic
`Synthesis of Chiral Amino Alcohols: A Concise Transketolase / ω-Transaminase-Mediated Synthesis of
`(2S,3S)-2-Aminopentane-1,3-diol. (10.1021/op900190y)
`
`
`77. Wohlgemuth R, Smith MEB, Dalby PA and Woodley JM (2010) Transketolases. In Encyclopedia of
`Industrial Biotechnology: Bioprocess, Bioseparation and Cell Technology, Ed, Michael C. Flickinger, Vol.
`7 pp 4746-4752. John Wiley and Sons, Inc, Hoboken.
`
`
`78. Grant, Y., Matejtschuk, P., Dalby, P.A. (2009) Biotech. Bioeng. 104(5), 957-964. Rapid optimisation of
`protein freeze-drying formulations using ultra scale-down and factorial design of experiment in
`microplates. (DOI 10.1002/bit.22448)
`
`
`79. Hailes, H.C., Dalby. P.A., Lye, G.J., Ward, J.M. (2009) Chim Oggi. 27(4), 28-31. Biocatalytic Approaches
`to Ketodiols and Aminodiols.
`
`
`80. Dalby. P.A., Baganz, F.B., Lye, G.J., Ward, J.M. (2009) Chim Oggi. 27(4), 18-22. Protein and pathway
`engineering in biocatalysis.
`
`
`81. Dalby, P. (2009) J. Biomolecular Screening 14(7), 900-900. High-Throughput Characterization of Proteins
`From Microtiter Plates to Microfluidics. 15th Annual Conference and Exhibition of the Society-of-
`Biomolecular-Sciences, APR 26-30, 2009 Lille, France.
`
`
`82. Paramesvaran, J., Hibbert, E.G., Russell, A.J., Dalby, P.A. (2009) Protein Engineering Design and
`Selection. 22(7), 401-411. Distributions of enzyme residues yielding mutants with improved substrate
`specificities from two different directed evolution strategies. (DOI 10.1093/protein/gzp020)
`
`
`83. Mannall, G.J, Myers, J.P., Liddell J., Titchener-Hooker, N.J., Dalby, P.A. (2009) Biotech. Bioeng. 103(2),
`329-340. Ultra scale-down of protein refold screening in microwells: Challenges, solutions and application.
`(DOI 10.1002/bit.22245)
`
`
`84. Polykarpou, E.M., Dalby, P.A. and Papageorgiou, L.G. (2009) An MINLP formulation for the synthesis of
`chromatographic protein purification processes with product loss. 19th European Symposium on Computer
`Aided Process Engineering – ESCAPE19. J. Jeżowski and J. Thullie (Editors)
`
`
`85. Smith, M.E.B., Hibbert, E.G., Jones, A.B., Dalby, P.A, and Hailes, H.C. (2008) Adv Syn Catal 350, 2631-
`2638. Enhancing and reversing the enantioselectivity of E. coli transketolase via single point
`mutations. (DOI 10.1002/adsc.200800489)
`
`
`86. Chen, B.H., Hibbert, E.G., Dalby, P.A., and Woodley, J.M. (2008) AIChE J. 58, 2155-2163. A new
`approach to bioconversion reaction kinetic parameter identification. (DOI 10.1002/aic.11545)
`
`
`87. Hibbert, E.G., Senussi, T., Smith, M.E.B., Costelloe, S.J., Ward, J.M., Hailes, H.C., and Dalby, P.A.
`(2008) J. Biotechnol. 134, 240-245. Directed evolution of transketolase substrate specificity towards an
`aliphatic aldehyde. (DOI 10.1016/j.jbiotec.2008.01.018)
`
`
`88. Aucamp, J.P., Martinez-Torres, R.J., Hibbert, E.G. and Dalby, P.A. (2008) Biotech. Bioeng. 99, 1303-1310.
`A microplate-based evaluation of complex denaturation pathways: Structural stability of E. coli
`transketolase. (DOI 10.1002/bit.21705) Cover of issue 99(6) 2008, April 15.
`
`
`
`MPI EXHIBIT 1008 PAGE 9
`
`DR. REDDY’S LABORATORIES, INC.
`IPR2024-00009
`Ex. 1008, p. 9 of 22
`
`

`

`89. Costelloe, S.J., Ward, J.M., and Dalby, P.A. (2008) J. Mol. Evol. 66, 36-49. Evolutionary analysis of the
`TPP-dependent enzyme family. DOI 10.1007/s00239-007-9056-2)
`
`
`90. Dalby, P.A., Aucamp, J.P., George, R. and Martinez-Torres, R.J. (2007) Biochem. Soc. Transact. 35, 1606-
`1609. Structural stability of an enzyme biocatalyst. DOI:10.1042/BST0351606
`
`
`91. Hibbert, E.G., Senussi, T., Costelloe, S.J., Lei, W., Smith, M.E.B., Ward, J.M., Hailes, H.C., and Dalby,
`P.A. (2007) Journal of Biotechnology 131, 425-432. Directed evolution of transketolase activity on non-
`phosphorylated substrates. (10.1016/j.jbiotec.2007.07.949)
`
`
`92. Hailes, H.C., Dalby, P.A. and Woodley, J.M. (2007) J. Chem. Technol. Biotechnol. 82, 1063–1066.
`Integration of biocatalytic conversions into chemical syntheses.
`
`
`93. Miller, O.J., Hibbert, E.G., Ingram, C.U., Lye, G.J., Dalby, P.A. (2007) Biotechnol. Letts. 29(11):1759-
`1770. Optimisation and evaluation of a generic microplate-based HPLC screen for
`transketolase. DOI: 10.1007/s10529-007-9435-1
`
`
`94. Martinez-Torres, R.J., Aucamp, J.P., George, R. and Dalby, P.A. (2007) Enzyme Microb. technol. 41, 653-
`662. Structural stability of E. coli transketolase to urea denaturation. (DOI:
`10.1016/j.enzmmictec.2007.05.019)
`
`
`95. Mannall, G. J., Titchener-Hooker, N. J. and Dalby, P. A. (2007) Biotech. Bioeng. 97, 1523-1534. Factors
`affecting protein refolding yields in a fed-batch and batch-refolding system. (DOI: 10.1002/bit.21377)
`
`
`96. Dalby, P. A. (2007) Recent Patents Biotechnol. 1 (1), 1-9. Engineering enzymes for biocatalysis.
`
`97. Ingram, C. U., Bommer, M., Smith, M. E. B., Dalby, P. A., Ward, J. M., Hailes, H.C., Lye, G. J. (2007)
`Biotech. Bioeng. 96, 559-569. One-pot synthesis of amino-alcohols using a de-novo transketolase and -
`alanine:pyruvate transaminase pathway in Escherichia coli. DOI: 10.1002/bit.21125
`
`
`98. Dimitriadou, E.K., Lye, G.J., Dalby, P.A. (2007) Redesign

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket